https://www.indianpharmapost.com/indias-bioeconomy-to-reach-us-300-billion-by-2030-dr-jitendra-singh-160882024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/ec-approves-ordspono-for-the-treatment-of-relapsedrefractory-follicular-lymphoma-and-diffuse-large-b-cell-lymphoma-160892024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-receives-ec-approval-for-winrevair-for-treatment-of-pah-160902024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/mangalam-drugs-organics-awarded-us-274800-grant-by-mmv-160912024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-receives-usfda-approval-for-bortezomib-injection-160922024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/roches-piasky-approved-in-the-eu-as-the-first-monthly-subcutaneous-treatment-for-people-with-pnh-160932024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/bristol-myers-squibb-to-present-data-across-cardiovascular-portfolio-at-ecs-2024-160942024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-launches-digital-platform-pfizerforall-160952024-08-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-announces-phase-3-trial-initiation-for-bomedemstat-160962024-08-27T00:00:00+05:30always0.9